180 related articles for article (PubMed ID: 15793665)
1. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
Shimanuki Y; Takahashi K; Cui R; Hori S; Takahashi F; Miyamoto H; Fukurchi Y
Lung; 2005; 183(1):29-42. PubMed ID: 15793665
[TBL] [Abstract][Full Text] [Related]
2. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
3. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.
Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y
Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617
[TBL] [Abstract][Full Text] [Related]
4. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
5. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum VEGF concentration and prognosis of lung cancer.
Park SH; Lee SS
Korean J Intern Med; 2003 Dec; 18(4):207-11. PubMed ID: 14717227
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Circulating Osteopontin Levels in Patients With Lung Cancer and Correlation With VEGF and MMP-9.
Kerenidi T; Kazakou AP; Lada M; Tsilioni I; Daniil Z; Gourgoulianis KI
Cancer Invest; 2016 Sep; 34(8):385-92. PubMed ID: 27624849
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Laack E; Scheffler A; Burkholder I; Boeters I; Andritzky B; Schuch G; Görn M; Vohwinkel G; Edler L; Fiedler W; Hossfeld DK
Lung Cancer; 2005 Oct; 50(1):51-8. PubMed ID: 15992959
[TBL] [Abstract][Full Text] [Related]
11. [Changes in serum vascular endothelial growth factor and matrix metalloproteinase-9 after video-assisted thoracoscopic surgery and thoracotomic Lobectomy in the treatment of patients with non-small cell lung cancer].
Tian W; Tong H; Sun Y; Wu Q; Ma C; Jiao P
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):24-9. PubMed ID: 24398310
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
13. MMP-9/ANC score as a predictive biomarker for efficacy of bevacizumab plus platinum doublet chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer.
Hiura K; Shiraishi A; Suzuki C; Takamura K; Yamamoto M; Komori H; Watanabe Y; Iwaki-Egawa S
Cancer Biomark; 2015; 15(4):433-40. PubMed ID: 25835177
[TBL] [Abstract][Full Text] [Related]
14. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
16. Serum cripto-1 as a clinical marker for lung cancer.
Xu CH; Cao L; Wei Y; Yu LK
Int J Biol Markers; 2015 Nov; 30(4):e369-73. PubMed ID: 26109366
[TBL] [Abstract][Full Text] [Related]
17. [Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer].
Zhao J; Liu XY; Zhang QY; Jiang W
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):676-9. PubMed ID: 16438890
[TBL] [Abstract][Full Text] [Related]
18. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Predictive Role of Angiogenic Markers in Non- Small Cell Lung Cancer.
Keskin S; Kutluk AC; Tas F
Asian Pac J Cancer Prev; 2019 Mar; 20(3):733-736. PubMed ID: 30909672
[TBL] [Abstract][Full Text] [Related]
20. Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients.
Garpenstrand H; Bergqvist M; Brattström D; Larsson A; Oreland L; Hesselius P; Wagenius G
Med Oncol; 2004; 21(3):241-50. PubMed ID: 15456951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]